BioMed Central, Journal of Translational Medicine, 1(12), 2014
Full text: Download
Background: Alterations in key-regulator genes of disease pathogenesis ( BRAF , cKIT , CyclinD1 ) have been evaluated in patients with multiple primary melanoma (MPM). Methods: One hundred twelve MPM patients (96 cases with two primary melanomas, 15 with three, and 1 with four) were included into the study. Paired synchronous/asynchronous MPM tissues (N = 229) were analyzed for BRAF mutations and cKIT/CyclynD1 gene amplifications. Results: BRAF mutations were identified in 109/229 (48%) primary melanomas, whereas cKIT and CyclinD1 amplifications were observed in 10/216 (5%) and 29/214 (14%) tumor tissues, respectively. While frequency rates of BRAF mutations were quite identical across the different MPM lesions, a significant increase of cKIT (p